Campylobacter fetus Peritonitis in a Patient with Continuous Ambulatory Peritoneal Dialysis: A First Case Report in Korea

Kyuhwa Hur; Eunyoung Lee; Jongmyeong Kang; Yangsoon Lee

doi:10.5145/ACM.2018.21.1.20

Journal List > Ann Clin Microbiol > v.21(1) > 1099913

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Hur, Lee, Kang, and Lee: Campylobacter fetus Peritonitis in a Patient with Continuous Ambulatory Peritoneal Dialysis: A First Case Report in Korea

Original Article

Ann Clin Microbiol 2018;21(1):20-22.

Published online: 12 March 2018

DOI: https://doi.org/10.5145/ACM.2018.21.1.20

Campylobacter fetus Peritonitis in a Patient with Continuous Ambulatory Peritoneal Dialysis: A First Case Report in Korea

Kyuhwa Hur¹, Eunyoung Lee¹, Jongmyeong Kang², Yangsoon Lee¹

^¹Departments of Laboratory Medicine, Hanyang University College of Medicine, Seoul, Korea

^²Internal Medicine, Hanyang University College of Medicine, Seoul, Korea

Correspondence: Yangsoon Lee, Department of Laboratory Medicine, Hanyang University College of Medicine, 222-1 Wangsimni-ro, Seongdong-gu, Seoul 04763, Korea. (Tel) 82-2-2290-9655, (Fax) 82-2-2290-9193, (E-mail) yangsoon@hanyang.ac.kr

Received 10 November 2017 Revised 28 October 2017 Accepted 25 January 2018

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Campylobacter fetus may cause infections such as septicemia, peritonitis, meningitis, endocarditis, septic arthritis, and cellulitis, increasing the risk of spontaneous abortion but decreasing the likelihood of gastroenteritis. We identified C. fetus from continuous ambulatory peritoneal dialysis (CAPD) fluid using 16S rRNA gene sequencing. It is significant that this is the first case report in Korea of CAPD peritonitis caused by C. fetus, which is known to be rare.

Keywords: Campylobacter fetus, Continuous ambulatory peritoneal dialysis, Peritonitis, 16S rRNA

References

1. Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott's Diagnostic Microbiology. 12nd ed.St. Louis: Mosby;2007. p. 418–20.

2. Gazaigne L, Legrand P, Renaud B, Bourra B, Taillandier E, Brun-Buisson C, et al. Campylobacter fetus bloodstream infection: risk factors and clinical features. Eur J Clin Microbiol Infect Dis. 2008; 27:185–9.

3. Elshafie SS, Asim M, Ashour A, Elhiday AH, Mohsen T, Doiphode S. Campylobacter peritonitis complicating continuous ambulatory peritoneal dialysis: report of three cases and review of the literature. Perit Dial Int. 2010; 30:99–104.

4. Kim US, Shin JI, Shin JW, Kim SG, Kim YS, Oh MD, et al. A case of septic pneumonia secondary to community: acquired Campylobacter fetus bacteremia. Korean J Infect Dis. 2002; 34:73–7.

5. Romero Gómez MP, García-Perea A, Ruiz Carrascoso G, Bajo MA, Mingorance J. Campylobacter fetus peritonitis and bacteremia in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol. 2010; 48:336–7.

6. Kubota M, Ishiguro N, Tomino Y, Koide H. Campylobacter fetus subspecies fetus peritonitis in continuous ambulatory peritoneal dialysis. Nephron. 1993; 65:487–8.

7. Wood CJ, Fleming V, Turnidge J, Thomson N, Atkins RC. Campylobacter peritonitis in continuous ambulatory peritoneal dialysis: report of eight cases and a review of the literature. Am J Kidney Dis. 1992; 19:257–63.

8. Wens R, Dratwa M, Potvliege C, Hansen W, Tielemans C, Collart F. Campylobacter fetus peritonitis followed by septicaemia in a patient on continuous ambulatory peritoneal dialysis. J Infect. 1985; 10:249–51.

9. CLSI. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; Approved guideline. CLSI document M45-A2. Wayne, PA: Clinical and Laboratory Standards Institute;2010.

10. Chong YS, Lee KW, et al. eds. Current Diagnostic Microbiology. 4th ed.Seoul: Seo Heung Press;2009. p. 355–7.

11. Longo DI, Fauci AS, et al. Harrison's Principles of Internal Medicine. 19th ed.New York: McGraw-Hill;2015. p. 1058–61.

12. Cho IJ, Yim J, Lee Y, Kim MS, Seo Y, Chung HS, et al. Trends in isolation and antimicrobial susceptibility of enteropathogenic bacteria in 2001–2010 at a Korean tertiary care hospital. Ann Clin Microbiol. 2013; 16:45–51.

13. Kim SM, Kim EC, Choi MR, So HA, Shim ES, Kim ES, et al. Cytolethal distending toxin production, genotypes and atimicrobial susceptibility of Campylobacter jejuni isolates from diarrhea patients and chickens. J Bacteriol Virol. 2008; 38:207–19.

14. Bender FH, Bernardini J, Piraino B. Prevention of infectious complications in peritoneal dialysis: best demonstrated practices. Kidney Int Suppl. 2006; 103:S44–54.

TOOLS

Similar articles